chr22-50277956-C-T
Variant summary
Our verdict is Likely benign. The variant received -1 ACMG points: 2P and 3B. PM2BP4_ModerateBS1_Supporting
The NM_012401.4(PLXNB2):c.4945G>A(p.Ala1649Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000868 in 1,612,760 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_012401.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152166Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000282 AC: 7AN: 248664 AF XY: 0.0000296 show subpopulations
GnomAD4 exome AF: 0.00000753 AC: 11AN: 1460594Hom.: 0 Cov.: 37 AF XY: 0.0000110 AC XY: 8AN XY: 726640 show subpopulations
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152166Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74332 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.4945G>A (p.A1649T) alteration is located in exon 32 (coding exon 30) of the PLXNB2 gene. This alteration results from a G to A substitution at nucleotide position 4945, causing the alanine (A) at amino acid position 1649 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at